谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

HERIZON: A phase 2 study of HER-Vaxx (IMU-131), a HER2t-argeting peptide vaccine plus SOC chemotherapy in patients with HER2+advanced stomach cancer - correlation of the antibody responses and clinical outcome

J. Tobias,M. Kundi,E. Garner-Spitzer,C. Zielinski,M. Maglakelidze,Z. Andric,Z. Petrovic,R. Nagarkar,T. Chawla,L. Chong,B. Nixon,S. Yavrom,N. Ede,U. Wiedermann

Annals of Oncology（2023）

引用 0|浏览33
暂无评分
关键词
peptide vaccine,soc chemotherapy,her-vaxx
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要